GB2306109A - A zinc containing composition for treating the common cold - Google Patents

Abstract

The composition comprises amino acids, zinc, ascorbic acid (Vitamin C) and aspirin (acetylsalicylic acid). The amino acids, which are chelated by the zinc, promote zinc uptake across mucosal surfaces such as the gut. Vitamin C and aspirin are intended to promote intranasal uptake of the composition. The composition is in a dry powder form which may be incorporated into capsules or provided as a compressed tablet.

Description

RATIONALE FOR A COMMON COLD PROPHYLACTIC THERE APPEARS TO BE NO RESEARCH DATA AVAILABLE WHICH DIFFERENTIATES THE PHYSIOLOGICAL DIFFERENCE BETWEEN PERSONS WHO CATCH COLDS AND THOSE WHO DO NOT. AND YET THIS UNDERSTANDING WHICH NEEDS TO BE ESTABLISHED IS VITAL BECAUSE THE COMCLUSION TO BE DRAWN IS THAT THE PERSON WHO DOES NOT CATCH COLD @OSSESSES ANTI - VIRAL QUALITIES.

THE RHINOVIRUS, WHICH IS RESPONSIBLE, HAS AT LEAST 100 VARIANTS AND YET THAT PERSON RESISTS THEM ALL DES@ITE THEIR DIFFERENT@ CHARACTERISTICS. THE TAXONOMIC GROUPS OF VIRUSES ( FA@ILIES) NUMBER AT LEAST 18 AND THEY ARE ALSO DIVIDED IMTO SUB-FA@ILIES AND THOSE INTO VARIANTS.

ALL VIRUSES ARE DIFFERENT FROM EACH OTHER, IN SIZE, CONSTRUCTION, AND CONTENTS. IN ORDER TO EFFECT ENTRY INTO A POTENTIAL HOST CELL THEY EITHER INJECT OR INVADE.

HOWEVER, THE MODUS OPERANDI FOR ALL VIRUSES AT THE BEGINNING OF THE CYCLE OF INFECTION COMMENCES WITH THE SAME TWO STEPS. THE FIRST IS ASSIDENTAL- LANDING ON THE CELL. THE SECOND INVOLVES ATTACHING TO THE CELL SURFACE (ADSORBTION). AS VIRUSES ARE PARASITES THIS STEP IS VITAL IF THEY ARE TO PROCEED TO STEP THREE.

IT IS OBVIOUS FROM THIS THAT IF THOSE FIRST TWO STEPS CAN BE PREVENTED, THE VIRUS WILL BE MEUTRALISED. DENY THEM ACCESS TO THE NASAL MUCOSA AND THEY WILL REMAIN PASSIVE.

A PERSON WITH THIS ABILITY MUST BE DEEMED IMPERVIOUS TO VIRUSES A'1' THAT SIR OF INFECTION.

ESSENTIALY THE COMMON COLD IS A LOCAL AND SUPERFICIAL RESPONSE TO THE VIRUS, SOMEWHAT SIMILAR TO THAT CAUSED BY POLLEN AND PENETRATION TO THE BLOODSTREAM DOES NOT TAKE PLACE.

THEREFORE A T OR B CELL RESPONSE IS NOT INVOLVED.

ZINC IS NOT A NUTRIENT AS SUCH BUT IT IS VITAL IN THE STANDING FLUIDS OF THE BODY. IT IS PRESENT IN THE S@IN AND PERSPIRATION, IN THE PROSTATIC FLUIDS INCLUDING SEMEN, IN THE EYES AND BRAIN AND THE INTERNAL SURFACES SUCH AS THE MUCOUS MEMBRANES.

IN A PERSON OF LOW ZINC STATUS NOT ALL ORGANS GET THEIR OPTIMUM LEVEL DUE TO A @UIRK OF THEIR METABOLISM. WHEN THIS OCCURS AND THE MASAL @UCOSA ARE AFFECTE@ A@ INABILITY TO RESIST VIRSUSES EXISTS.

DES@ITE ACTIVE RESEARCH, THE METABOLIC ORIGINS OF THE @ATHOLIGICAL CHANGES CAUSED BY ZINC DEFICIENCY ARE @OORLY UNDERSTOOD. DIAG@DSTIC CRI@@RIA IS IAC@ING FOR MARGINAL DEFIC@HNCY AND THERE IS ALMOST NO SOIE@TIFIC DATA @@R SE@TING R@COMMENDATIONS FOR ZINC INTAKE.

ZINC HAS A VITAL ROLE IN THE STRUCTURE AND FUNCTIONS OF THE BODY AND IS ESSENTIAL. FOR THE IMM@@E DEFENCE SYSTEM, IN FACE, FRC@T LINE WHERE AIRBO@R@E VIRUSES ARE CO@C@R@ED AT THE SITHS OF INFECTION.

S@B @@TIMAL ZINC LEVELS IN EXPERIMENTAL ANIMALS CAUSED A REDUCTION IN LEUCOCYTES DUE TO WASTING OF THE THYMUS GLAND. HOWEVER, LEUCOCYTES ARE NOT INVOLVED IN RESISTANCE TO COLDS.

THE MECH@@ISMS FOR ZINC ABSORBTION AND THE FACTORS CONTRCILING IT ARE @OORLY UND@RST@OD . ONE DIETARY FACTOR KMOWN TO AFFECT ZINC APSORBTION IS @HY@IC ACID. CHIS IS FO@D IN WHOLEGRAIN CEREALS, LEGUMES , @HCIEMEA@ BREA@, SOY FORM@IA AND OTHER VEGETABLES.

AT THE @h VALUES FOU@I I@ FOODS, PHYTIC ACID WILL BE MEGATIVELY CHARGED AND WILL BIND TO POSITIVELY CHARGED MOLECULES SUCH AS ZINC AND SO IMPAIR THEIR ABSORBTION.

THE COMPOUND ENABLES A HIGHER STANDING LEVEL OF ZINC TO EXIST IN THE BODY THAN WOULD OTHERWISE BE THE CASE.

LO'T ZI?C STATUS IS DUE TO MALABSORBTION WHEN DIET IS DiOT IS NOT THE CAUSE. HIGHER DIETARY INTAKE EVEN INCLUDING SUPPLEMENTS MAKES LITTLE OR NO DIFFERENCE.

THIS IS DUE IN THE MAIN TO THE LARGE ZINC MOLECULES BEING UNABLE TO DIFFUSE THROUGH THE GUT WALL AND SO GOING TO WASTE.

AMINO ACID CHELATION INVOLVES CHEMICAL CLEAVAGE OF THE ZINC MOLECULES AND SURROUNDING THEM WITH AND BONDING THEN TO AMINO ACIDS IN A STABLE FORM FROM RICE PROTEIN. THIS PROVIDES A MATURAL MEANS FOR TRANSPORT ACROSS THE GUT AND IMCREASES THE AVAILABILITY TO THE BODY.

THE ASCORBIC ACID AND ACETYL SALYCYCLIC IMPROVE THE TRANSPORT TO AND CONDITION OF THE NASAL MUCOSA AND OFFERS A SOUND MEMBRANE FOR THE DIFFUSION OF THE ZINC. THE AGGREGATE BECOMES AN INTERACTIVE MIXTURE WITH A CONSEQUENT SYNERGISTIC EFFECT.

DESPITE THE MANUFACTURERS ASSERTION OF HIGHER TRANSIENT ZINC LEVELS IT IS NOT ENOUGH TO RAISE THEM TO OPTIMUM IN THE BODY WITHOUT THE SALICYCLIC ACID AND ASCORBIC TO COMPLETE THE REACTION. AMINO ACIDS ARE 95% ABSORBED WHEREAS DIETARY ZINC CAN BE AS LOW AS 5% .

EXACTLY WHAT HAPPENS AT THE MEMBRANE SURFACE WHEN VIRUSES ARE NEUTRALISED IS NOT KNOWN, BUT THERE ARE OPTIONS .

THE ZINC IS TOXIC TO THE VIRUSES THE ZINC REPELS THE VIRUSES WITH IT'S POSITIVE CHARGE. THE ZINC INCREASES THE SURFACE TENSION OF THE MEMBRANE, SO PREVENTING THE VIRUSES FROM PENETRATING.

CHELATION.

THE BODY IS VERY EFFICIENT AT ABSORBING AMINO ACIDS WITH A.

RATE OF 95 per cent. CHELATING TRACE ELEMENTS TO THESE ACIDS ALLOWS THEM TO BE DIFFUSED IN THE TRANSPORT PROCESS ACROSS THE GUT WALL.

SPECIAL PROCESSES ARE PERFORMED WHICH CREATES A STABLE ( COVALENT ) BOND WHICH IS IMPORTANT TO SECURE A HIGH RATE OF AVAILABILITY.

LARGE PARTICLES CANNOT EASILY PASS THROUGH THE GUT WALL AND MANY TRACE ELEMENTS HAVE MOLECULAR WEIGHTS TO LARGE TO BE ABSORBED INTACT.

THE PROCESS OFFERS ph BUFFERED STABILITY OF THE ELEMENTS. STABILITY IS MAINTAINED EVEN IN THE ACIDIC ENVIRONMENT OF DIGESTION ph@l.

ESSENTIALLY, CHELATING TURNS INORGANIC MINERALS INTO SMALL ORGANIC MOLECULES. THIS MAKES THEM MORE AVAILABLE AS THEY REMAIN INTACT AND DURABLE THROUGH DIGESTION.

THE SCIENTIFIC DEFINITION OF METAL AMINO ACID CHELATES IS , THE PRODUCT RESULTING FROM THE REACTION OF A METAL ION WITH AMINO ACIDS HAVING A MOLE RATIO OF ONE MOLE OF METAL TO ONE TO THREE MOLES OF AMINO ACIDS TO FORM COORDINATE COVALENT BONDS. THE RESULTING MOLECULE HAS TWO OR THREE FIVE-MEMBER HETEROCYCLIC RING STRUCTURES CONTAINING A METAL ION ( AS THE CLOSING MEMBER OF THE RING ). THE METAL ION IS ATTACHED BY COORDINATE COVALENT BONDS TO TWO OR MORE NON METALS IN THE SAME MOLECULE.

DESCRIPTION.

A PHARMACEUTICAL COMPOUND WITH THREE COMPONENTS WHICH IS AN EFFECTIVE PROPHYLACTIC FOR THE COMMON COLD (CORYZA).

A PHARMACEUTICAL COMPOSITION COMPRISING 50 to 100 mgs OF ASCORBIC ACID 15 to 30 mgs OF AMINO ACID CHELATED ZINC 300 mgs ASPIRIN - IN DRY POWDER FORM AS TABLETS OR CAPSULES .

DOSAGE IS.ANY COMBINATION OF THE ABOVE IN THE PREFERRED FORM. TAKEN DAILY, WITH.@SPIRIN LIMITED TO 300 mgs PER DAY.

Claims (1)

1. CLAIM.

   A PHARMACEUTICAL COMPOUND FOR PREVENTING THE COMMON COLD AS CLAIMED IN CLAIM 1 AND COMPRISING A MIXTURE OF 100 mgs ASCORBIC ACID, 15 mgs AMINO ACID CHELATED ZINC AND 300 mgs ASPIRIN.

   THE NOVELTY OF THE CLAIM IS IN THE COMBINATION OF THE THREE ELEMENTS AND THE CHOICE OF THE INGREDIENTS IN THE CORRECT QUANTITIES.

   Amendments to the claims have been filed as follows CLAIM A PHARMACEUTICAL COMPOUND - SPECIFIC NAME 'ARMOUR' WHICH IS EFFECTIVE AGAINST CERTAIN VIRUS CAUSED ILLNESSES BOTH AS A PREVENTATIVE AND AS A CONTROL.

   IT IS A PREVENTATIVE FOR THE COMMON COLD.

   IT IS A PREVENTATIVE FOR HERPES SIMPLEX.

   IT WILL CONTROL HERPES SIMPLEX..

   IT IS A PREVENTATIVE FOR AN ENLARGED PROSTATE GLAND.

   iT WILL NORMALISE AN ENLARGED PROSTATE GLAND.

   THE COMPOUND IS COMPRISED OF 100mgs. ASCORBIC ACID, 15.30 mgs. CHELATED ZINC AND 1-300mg. ASPR[N. THE NOVELTY OF THE CLAIM IS IN THE COMBINATION OF THE THREE ELEMENTS, THE CHOICE OF THE [NGREDIENTS IN THE SPECIFIED QUANTITIES AND THE USE OF S.T.I. (STOMACH TISSUE INFILTRATION) TO ACHIEVE THE RESULTS.